Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti–PD-L1 Immunotherapy
Bin Yi(Louisiana State University Health Sciences Center New Orleans), Yaguang Xi(USA Mitchell Cancer Institute)
Cited by 10
Related Papers
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo
|Scientific Reports|2016|239
MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit
|Cell Death and Differentiation|2011|151